Careloop GmbH has been acquired by Klett Group
The founders and the investor consortium of Careloop GmbH have sold a majority stake to Klett Group in the next phase of their growth strategy.
Careloop is a technology driven end-to-end platform for healthcare groups to recruit, educate and retain international medical professionals. Active in the healthcare staffing market, Careloop has redesigned the recruitment of international medical professionals by digitizing the process and making it cost efficient and convenient for all parties. The company’s shareholders consisted of leading venture capital firms, such as IBB Ventures, Redstone and the Swiss Founders Fund, as well as the founders of the company and business angels.
The Klett Group is one of Europe’s leading educational companies, spanning sectors from early childhood education to adult learning and publishing. With operations in 18 countries, it fosters lifelong learning through tailored educational solutions. The company is also actively involved in recruiting foreign professionals, addressing the skills shortage and enhancing the education sector with global talent.
Oaklins’ team in Germany acted as the exclusive advisor to the shareholders and management of Careloop in the preparation of the sale process and due diligence, the approach and negotiations with the preferred buyer, and assisted them until closing.
Alexander Lundberg
Founder and CEO, Careloop
Talk to the deal team
Related deals
Valmiermuižas Alus has been acquired by Cēsu Alus
Valmiermuižas Alus has been acquired by Cēsu Alus AS through the purchase of 100% of its shares. The transaction enabled the founder’s exit and strengthened the company’s platform for continued growth within a consolidating Baltic beverage market.
Learn moreLindenhofgruppe has sold its majority stake in LabPoint to Affidea Switzerland
LabPoint Medical Laboratories AG has been acquired by Affidea Switzerland AG. Through the transaction, Lindenhofgruppe AG gains a strong strategic partner to support the further development of LabPoint and will remain a shareholder with a reduced stake, continuing as a key customer of the company. It lays the foundation for LabPoint’s sustainable development under a new anchor shareholder, with the aim of further strengthening and selectively expanding its position in laboratory diagnostics.
Learn moreArmira has signed an agreement to acquire a majority stake in Viabus
Armira, a Germany-based investment firm, has signed an agreement to acquire a majority stake in Viabus, a leading Dutch tour operator focused on senior and young senior travelers.
Learn more